DY Patil

DY Patil Medical College, Hospital and Research Center

Pimpri, Sant Tukaram Nagar
Pune, Maharashtra 
411018 India

+91 20 2780 5000.
medical.dpu.edu.in

  • Hospital is a 1470-bed private facility; existing partnership with Global Health Leadership Program at Johns Hopkins Medicine
  • Hopkins medical and nursing students attend 4-week interprofessional clinical electives; 4th year medical students and masters and doctoral nursing students are eligible for clinical rotations, coordinated by Dr. Vidya Mave
  • DY Patil is a clinical site for ongoing studies on the impact of diabetes on tuberculosis treatment outcomes, also looking at use of mobile health technology for directly-observed therapy
  • Monthly HIV Case Conference conducted among 5 Indo US institutions  
  • CIDI faculty members-Drs. Bollinger and Gupta hold adjunct faculty appointments at DY Patil and provide training lectures annually

Tuberculosis (TB) Aftermath

Post Date: 
2020-06-05
   |   
Countries: 
India
   |   
Clinical Sites: 
DY Patil
Drs. Vidya Mave and Jonathan Golub are co-PIs and Dr. Barthwal from DY Patil Medical College is local site PI for this study. TB Aftermath seeks to provide evidence for an effective and scalable strategy targeting HHs of treated TB cases, a high priority of the NTEP. Purpose To compare the...

Hybrid Trial for Alcohol Reduction among People with TB and HIV in India

Post Date: 
2020-02-12
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
Dr. Geetanjali Chander is PI and Dr. Kakrani is local site PI at DY Patil Medical College for this study. The highest incidence of tuberculosis disease (TB) in the world is in India, accounting for 27% of all new cases globally, with approximately 86,000 among persons with HIV (PWH). Unhealthy...

Implementing the Comprehensive Unit-based Safety Program to Reduce Healthcare-Associated Sepsis in the Neonatal Intensive Care Unit in Pune, India

Post Date: 
2018-04-19
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
This study is part of CDC's Safe Healthcare, Epidemiology, and Prevention Research Development (SHEPheRD) Program under Domain 7: International HAI and Other Adverse Healthcare Event Prevention. Dr. Aaron Milstone is the PI, and Dr. Amita Gupta and Yuka Manabe are Co-PIs. The Study...

Healthcare-Associated Sepsis in the Neonatal Intensive Care Unit in Pune, India

Post Date: 
2017-01-17
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
This study is part of CDC's Safe Healthcare, Epidemiology, and Prevention Research Development (SHEPheRD) Program under Domain 7: International HAI and Other Adverse Healthcare Event Prevention. Johns Hopkins neonatologist Dr. Julia Johnson is lead investigator for a systematic study of the...

Tuberculosis Noon Conference

Post Date: 
2013-10-24
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
Hinduja Hospital
NIRT
This effort ended in 2015. As part of the BJGMC-Johns Hopkins India Fogarty Training Program, from 2013-2015 CCGHE hosted the live Tuberculosis Noon Conference webcast. Led by Drs. Maunank Shah, Jonathan Golub, and Richard Chaisson, these webcast meetings brought together Johns Hopkins TB...

Impact of Diabetes on TB Treatment Outcomes

Post Date: 
2013-02-01
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
CCGHE, the JHU Center for TB Research and BJGMC have been awarded a $2.5 million dollar NIH grant (2013-2018) to conduct a study to evaluate treatment outcomes among Indian patients with both diabetes mellitus and active TB. This study is assessing the prevalence of impaired glucose or frank...

Bacterial Antimicrobial Resistance Patterns in Pune, India

Post Date: 
2013-01-10
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
This study was terminated September 24, 2019. Evaluate etiology of acute fever and bacterial drug resistance patterns among adults and children in India.

Use of smartphone-based video Directly Observed Therapy (vDOT) in tuberculosis care: Single-arm, prospective feasibility study

Post Date: 
2019-08-30
   |   
Countries: 
India
   |   
Clinical Sites: 
DY Patil
Publication: 
Journal of Medical Internet Research
Video-based monitoring is increasingly used as an efficient and low cost alternative to in-person observation and monitoring of TB patients. It showed promise in the high TB setting of India, too.

The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment

Post Date: 
2018-08-20
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
NIRT
Publication: 
Antimicrobial Agents and Chemotherapy
DM and higher HbA1c increased the risk of not achieving therapeutic targets for pyrazinamide, but higher pyrazinamide concentrations were asociated with worse microbiologic and clinical outcomes

Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India

Post Date: 
2018-07-01
   |   
Countries: 
India
   |   
Clinical Sites: 
BJGMC
DY Patil
Publication: 
International Journal of Tuberculosis and Lung Disease
SETTING: The optimal timing of screening for diabetes mellitus (DM) among tuberculosis (TB) cases is unclear due to the possibility of stress hyperglycemia. DESIGN: We evaluated adult (18 years) pulmonary TB cases at treatment initiation as well as at 3 months,...
Subscribe to RSS - DY Patil